Table 1 Demographic, clinical and biochemical characteristics of study participants stratified by clinical conditions
Variable | Diabetes (n = 120) | Hypertension (n = 65) | Hypertension and diabetes (n = 23) | P-value |
|---|---|---|---|---|
Age (years) | 60.2 ± 10.1 | 60.8 ± 9.5 | 60.7 ± 8.6 | 0.913 |
Age group (years) | ||||
< 40 | 5 (4.2) | 1 (1.5) | 0 (0.0) | |
40–49 | 11 (9.2) | 8 (12.3) | 1 (4.3) | |
50–59 | 38 (31.7) | 16 (24.6) | 9 (39.1) | |
60–69 | 44 (36.7) | 27 (41.5) | 9 (39.1) | |
≥ 70 | 22 (18.3) | 13 (20.0) | 4 (17.4) | |
Sex | ||||
Male | 32 (26.7) | 21 (32.3) | 7 (30.4) | |
Female | 88 (73.3) | 44 (67.7) | 16 (69.6) | 0.795 |
Disease Duration (years) | 5.4 ± 2.4 | 5.2 ± 2.3 | 6.3 ± 3.4 | 0.192 |
Disease Duration Category | ||||
< 5 | 51 (42.5) | 30 (46.2) | 8 (34.8) | |
5–10 | 65 (54.2) | 32 (49.2) | 13 (56.5) | |
> 10 | 4 (3.3) | 3 (4.6) | 2 (8.7) | 0.721 |
FBG (mmol/l) | 9.7 ± 3.7 | 5.8 ± 1.4 | 13.4 ± 4.7 | <0.001 |
SBP (mmHg) | 130.3 ± 15.1 | 145.7 ± 22.8 | 160.0 ± 17.8 | <0.001 |
DBP (mmHg) | 75.1 ± 8.7 | 85.2 ± 10.2 | 94.8 ± 12.0 | <0.001 |
BMI (kg/m2) | 27.5 ± 5.2 | 27.4 ± 5.0 | 27.7 ± 5.6 | 0.966 |
BMI Category n(%) | ||||
Underweight | 3 (2.5) | 1 (1.5) | 0 (0.0) | |
Normal | 34 (28.3) | 19 (29.2) | 10 (43.5) | |
Overweight | 48 (40.0) | 29 (44.6) | 6 (26.1) | |
Obese | 35 (29.2) | 16 (24.6) | 7 (30.4) | 0.672 |
eGFR, mL/min/1.73 m2 | 82 ± 32 | 76 ± 26 | 61 ± 39 | 0.012 |